Capstone Therapeutics awarded distribution rights for Eldorado Stone

Capstone announced it has been awarded distribution rights for Eldorado Stone, a premium manufactured stone veneer brand from Westlake Royal Building Products. The Company expects the addition will contribute $5 million in annualized run-rate revenue by Q3 2027, sold entirely through Capstone’s existing distribution channels with no incremental infrastructure investment. “The addition of Eldorado Stone is a significant organic growth driver for our business,” said Matthew Lipman, Chief Executive Officer of Capstone. “We’ve built a strong track record distributing Cultured Stone, and Westlake’s decision to expand our portfolio with Eldorado reflects confidence in our platform and our ability to grow premium brands. This is $5 million in revenue that requires no acquisition cost and flows through a cost structure that is already in place.”